From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Does the Hemogenyx CEO work for free? Au Contraire: Pompous Twit on twitter pokes a bear

By Tom Winnifrith | Wednesday 26 February 2025


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I awake to find another tweet directed my way regarding Hemogenyx (HEMO), the unethical stock promote that will not cure cancer but says it might to promote its shares. This time it is not a shareholder accusing me of backing cancer but the CEO, Vlad Sandler who is tweeting. Vlad is pompous and seems to want to annoy me. He has and so I have done more digging!
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Sunday »

EZJ

BUY Easyjet

 

PDL

Petra Diamonds Remains a Short

 

Boom

Failed fund manager for PM!

 

Oil-Rig

Oilman Jim: is this legal?

Time left: 11:33:49